BridgeBio Pharma LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
BridgeBio Pharma LLC
CIK #0002076615, 0001743881
EDGAR Form CIK 2011 - 2025
10-K [0001743881]
10-Q [0001743881]
3 [0001743881]
4 [0001743881]
5 [0001743881]
8-K [0001743881]
SC 13D [0001743881]
SC 13G [0001743881]
3 [0002076615]
SC 13D [0002076615]
Form 13D/13G Filer Form 13D/13G Subject Filed
Bridgebio Pharma LLC Bridgebio Oncology Therapeutics Inc [2025-08-18]
State Street Corp Bridgebio Pharma Inc [2023-02-08]
Vanguard Group Inc Bridgebio Pharma Inc [2021-02-10]
BlackRock Inc Bridgebio Pharma Inc [2021-02-05]
Eidos Therapeutics Inc Bridgebio Pharma Inc [2020-10-15]
American International Group Inc Bridgebio Pharma Inc [2020-02-14]
Kumar Neil Bridgebio Pharma Inc [2020-02-14]
Perceptive Advisors LLC Bridgebio Pharma Inc [2019-07-11]
KKR Genetic Disorder LP Bridgebio Pharma Inc [2019-07-10]
Viking Global Investors LP Bridgebio Pharma Inc [2019-07-08]
View All
Form 3/4/5 Subject 2011 - 2025
BridgeBio Pharma, Inc.
Apuli Maricel
Trimarchi Thomas
Kumar Neil
BridgeBio Pharma LLC
BridgeBio Oncology Therapeutics, Inc.
Homcy Charles J
Ellis Andrea
Viking Global Opportunities Portfolio GP LLC
Viking Global Opportunities Illiquid Investments Sub-Master
View All
Terms | Privacy | Guide
tony@aum13f.com